151 related articles for article (PubMed ID: 32019778)
1. Immunosuppressive Mediators Impair Proinflammatory Innate Lymphoid Cell Function in Human Malignant Melanoma.
Ercolano G; Garcia-Garijo A; Salomé B; Gomez-Cadena A; Vanoni G; Mastelic-Gavillet B; Ianaro A; Speiser DE; Romero P; Trabanelli S; Jandus C
Cancer Immunol Res; 2020 Apr; 8(4):556-564. PubMed ID: 32019778
[TBL] [Abstract][Full Text] [Related]
2. Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors.
Cristiani CM; Capone M; Garofalo C; Madonna G; Mallardo D; Tuffanelli M; Vanella V; Greco M; Foti DP; Viglietto G; Ascierto PA; Spits H; Carbone E
Front Immunol; 2022; 13():811131. PubMed ID: 35173725
[TBL] [Abstract][Full Text] [Related]
3. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
Front Immunol; 2019; 10():217. PubMed ID: 30828332
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
Sevko A; Sade-Feldman M; Kanterman J; Michels T; Falk CS; Umansky L; Ramacher M; Kato M; Schadendorf D; Baniyash M; Umansky V
J Invest Dermatol; 2013 Jun; 133(6):1610-9. PubMed ID: 23223128
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model.
Sevko A; Michels T; Vrohlings M; Umansky L; Beckhove P; Kato M; Shurin GV; Shurin MR; Umansky V
J Immunol; 2013 Mar; 190(5):2464-71. PubMed ID: 23359505
[TBL] [Abstract][Full Text] [Related]
6. Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis.
Ryu S; Lee EY; Kim DK; Kim YS; Chung DH; Kim JH; Lee H; Kim HY
Arthritis Res Ther; 2020 Mar; 22(1):63. PubMed ID: 32223753
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cells in malignant melanoma.
Umansky V; Sevko A; Gebhardt C; Utikal J
J Dtsch Dermatol Ges; 2014 Nov; 12(11):1021-7. PubMed ID: 25263083
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune Responses.
Loyon R; Jary M; Salomé B; Gomez-Cadena A; Galaine J; Kroemer M; Romero P; Trabanelli S; Adotévi O; Borg C; Jandus C
Front Immunol; 2019; 10():2121. PubMed ID: 31555301
[TBL] [Abstract][Full Text] [Related]
9. Inflammation in uveal melanoma.
Bronkhorst IH; Jager MJ
Eye (Lond); 2013 Feb; 27(2):217-23. PubMed ID: 23238448
[TBL] [Abstract][Full Text] [Related]
10. Ongoing adaptive immune responses in the microenvironment of melanoma metastases.
van Baren N; Coulie PG
Ann N Y Acad Sci; 2013 May; 1284():62-5. PubMed ID: 23651195
[TBL] [Abstract][Full Text] [Related]
11. Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules.
Elemam NM; Hannawi S; Maghazachi AA
Toxins (Basel); 2017 Dec; 9(12):. PubMed ID: 29232860
[TBL] [Abstract][Full Text] [Related]
12. Innate lymphoid cells in antitumor immunity.
Salomé B; Jandus C
J Leukoc Biol; 2018 Mar; 103(3):479-483. PubMed ID: 29345362
[TBL] [Abstract][Full Text] [Related]
13. A TCM formula comprising Sophorae Flos and Lonicerae Japonicae Flos alters compositions of immune cells and molecules of the STAT3 pathway in melanoma microenvironment.
Liu YX; Bai JX; Li T; Fu XQ; Guo H; Zhu PL; Chan YC; Chou JY; Yin CL; Li JK; Wang YP; Chen YJ; Yu ZL
Pharmacol Res; 2019 Apr; 142():115-126. PubMed ID: 30797070
[TBL] [Abstract][Full Text] [Related]
14. Imbalance of Circulating Innate Lymphoid Cell Subpopulations in Patients With Septic Shock.
Carvelli J; Piperoglou C; Bourenne J; Farnarier C; Banzet N; Demerlé C; Gainnier M; Vély F
Front Immunol; 2019; 10():2179. PubMed ID: 31616411
[No Abstract] [Full Text] [Related]
15. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL.
Aspord C; Leccia MT; Charles J; Plumas J
Cancer Immunol Res; 2013 Dec; 1(6):402-15. PubMed ID: 24778133
[TBL] [Abstract][Full Text] [Related]
17. Isolation and Characterization of Innate Lymphoid Cells within the Murine Tumor Microenvironment.
Mallett G; Patterson W; Payne M; Amarnath S
Methods Mol Biol; 2020; 2121():153-164. PubMed ID: 32147794
[TBL] [Abstract][Full Text] [Related]
18. Melanoma-induced immunosuppression and its neutralization.
Umansky V; Sevko A
Semin Cancer Biol; 2012 Aug; 22(4):319-26. PubMed ID: 22349515
[TBL] [Abstract][Full Text] [Related]
19. Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.
Rudolph BM; Loquai C; Gerwe A; Bacher N; Steinbrink K; Grabbe S; Tuettenberg A
Exp Dermatol; 2014 Mar; 23(3):202-4. PubMed ID: 24495013
[TBL] [Abstract][Full Text] [Related]
20. Dissecting human ILC heterogeneity: more than just three subsets.
Simoni Y; Newell EW
Immunology; 2018 Mar; 153(3):297-303. PubMed ID: 29140572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
